Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples